Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy

S. A. Wayangankar, M. T. Roe, A. Y. Chen, R. S. Gupta, R. P. Giugliano, L. K. Newby, James A de Lemos, K. P. Alexander, T. A. Sanborn, J. F. Saucedo

Research output: Contribution to journalArticle

Abstract

Objective: To analyze trends in utilization of anti-thrombotic agents (ATA) and in-hospital clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients managed with an invasive strategy from 2007 to 2010. Methods & results: Using ACTION Registry®-GWTG™ data, we analyzed trends in use of ATA and in-hospital clinical outcomes among 64,199 NSTEMI patients managed invasively between 2007 and 2010. ATA included unfractionated heparin (UFH), low molecular weight heparin (LMWH), glycoprotein IIb/IIIa inhibitors (GPI) and bivalirudin. Although the proportion of NSTEMI patients treated with PCI within 48h of hospital arrival was similar in 2007 and 2010, percentage use of bivalirudin (13.4-27.3%; p

Original languageEnglish (US)
JournalIndian Heart Journal
DOIs
StateAccepted/In press - Aug 3 2015

Fingerprint

Platelet Glycoprotein GPIIb-IIIa Complex
Low Molecular Weight Heparin
Registries
Heparin
Non-ST Elevated Myocardial Infarction
bivalirudin

Keywords

  • Anti-thrombotic agents
  • Invasive strategy
  • Non-ST-segment elevation myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy. / Wayangankar, S. A.; Roe, M. T.; Chen, A. Y.; Gupta, R. S.; Giugliano, R. P.; Newby, L. K.; de Lemos, James A; Alexander, K. P.; Sanborn, T. A.; Saucedo, J. F.

In: Indian Heart Journal, 03.08.2015.

Research output: Contribution to journalArticle

Wayangankar, S. A. ; Roe, M. T. ; Chen, A. Y. ; Gupta, R. S. ; Giugliano, R. P. ; Newby, L. K. ; de Lemos, James A ; Alexander, K. P. ; Sanborn, T. A. ; Saucedo, J. F. / Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy. In: Indian Heart Journal. 2015.
@article{5213c01e58b349faaa0208615b0bc813,
title = "Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy",
abstract = "Objective: To analyze trends in utilization of anti-thrombotic agents (ATA) and in-hospital clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients managed with an invasive strategy from 2007 to 2010. Methods & results: Using ACTION Registry{\circledR}-GWTG™ data, we analyzed trends in use of ATA and in-hospital clinical outcomes among 64,199 NSTEMI patients managed invasively between 2007 and 2010. ATA included unfractionated heparin (UFH), low molecular weight heparin (LMWH), glycoprotein IIb/IIIa inhibitors (GPI) and bivalirudin. Although the proportion of NSTEMI patients treated with PCI within 48h of hospital arrival was similar in 2007 and 2010, percentage use of bivalirudin (13.4-27.3{\%}; p",
keywords = "Anti-thrombotic agents, Invasive strategy, Non-ST-segment elevation myocardial infarction",
author = "Wayangankar, {S. A.} and Roe, {M. T.} and Chen, {A. Y.} and Gupta, {R. S.} and Giugliano, {R. P.} and Newby, {L. K.} and {de Lemos}, {James A} and Alexander, {K. P.} and Sanborn, {T. A.} and Saucedo, {J. F.}",
year = "2015",
month = "8",
day = "3",
doi = "10.1016/j.ihj.2015.09.036",
language = "English (US)",
journal = "Indian Heart Journal",
issn = "0019-4832",
publisher = "Cardiology Society of India",

}

TY - JOUR

T1 - Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy

AU - Wayangankar, S. A.

AU - Roe, M. T.

AU - Chen, A. Y.

AU - Gupta, R. S.

AU - Giugliano, R. P.

AU - Newby, L. K.

AU - de Lemos, James A

AU - Alexander, K. P.

AU - Sanborn, T. A.

AU - Saucedo, J. F.

PY - 2015/8/3

Y1 - 2015/8/3

N2 - Objective: To analyze trends in utilization of anti-thrombotic agents (ATA) and in-hospital clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients managed with an invasive strategy from 2007 to 2010. Methods & results: Using ACTION Registry®-GWTG™ data, we analyzed trends in use of ATA and in-hospital clinical outcomes among 64,199 NSTEMI patients managed invasively between 2007 and 2010. ATA included unfractionated heparin (UFH), low molecular weight heparin (LMWH), glycoprotein IIb/IIIa inhibitors (GPI) and bivalirudin. Although the proportion of NSTEMI patients treated with PCI within 48h of hospital arrival was similar in 2007 and 2010, percentage use of bivalirudin (13.4-27.3%; p

AB - Objective: To analyze trends in utilization of anti-thrombotic agents (ATA) and in-hospital clinical outcomes in non-ST-elevation myocardial infarction (NSTEMI) patients managed with an invasive strategy from 2007 to 2010. Methods & results: Using ACTION Registry®-GWTG™ data, we analyzed trends in use of ATA and in-hospital clinical outcomes among 64,199 NSTEMI patients managed invasively between 2007 and 2010. ATA included unfractionated heparin (UFH), low molecular weight heparin (LMWH), glycoprotein IIb/IIIa inhibitors (GPI) and bivalirudin. Although the proportion of NSTEMI patients treated with PCI within 48h of hospital arrival was similar in 2007 and 2010, percentage use of bivalirudin (13.4-27.3%; p

KW - Anti-thrombotic agents

KW - Invasive strategy

KW - Non-ST-segment elevation myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84956486037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956486037&partnerID=8YFLogxK

U2 - 10.1016/j.ihj.2015.09.036

DO - 10.1016/j.ihj.2015.09.036

M3 - Article

C2 - 27543467

AN - SCOPUS:84956486037

JO - Indian Heart Journal

JF - Indian Heart Journal

SN - 0019-4832

ER -